Sjögren M, Minthon L, Davidsson P, Clarberg A, Vanderstichele H, Vanmechelen E, Wallin A, Blennow K
Institute of Clinical Neuroscience, Göbteborg University, Sahlgrenska University Hospital, Mölndal, Sweden.
J Neural Transm (Vienna). 2000;107(5):563-79. doi: 10.1007/s007020070079.
Cerebrospinal fluid (CSF) levels of tau, beta-amyloid(1-42) and growth-associated protein 43 (GAP-43) were studied in patients with frontotemporal dementia (FTD; n = 17), Alzheimer's disease (AD; n = 60), subcortical white-matter dementia (SWD; n = 24), Parkinson's disease (PD; n = 23) and dysthymia (n = 19) and in age-matched controls (n = 32). CSF-tau was significantly increased only in AD, and CSF-beta-amyloid(1-42) was significantly decreased in AD and SWD as compared to controls, and in AD compared to FTD. CSF-GAP-43 was significantly decreased only in PD. The GAP-43/tau ratio was decreased in all the patient groups except the dysthymia group compared to controls. A positive correlation was found between CSF-GAP-43 and CSF-tau in all groups. The results suggest normal levels of CSF-tau and CSF-beta-amyloid(1-42) in FTD, which will aid in the clinical separation of FTD from AD. In SWD, decreased levels of CSF-beta-amyloid(1-42) suggest concomitant involvement of vascular and amyloid protein mechanisms.
对额颞叶痴呆(FTD,n = 17)、阿尔茨海默病(AD,n = 60)、皮质下白质痴呆(SWD,n = 24)、帕金森病(PD,n = 23)和心境恶劣(n = 19)患者以及年龄匹配的对照组(n = 32)的脑脊液(CSF)中tau蛋白、β-淀粉样蛋白(1-42)和生长相关蛋白43(GAP-43)水平进行了研究。仅在AD患者中CSF-tau显著升高,与对照组相比,AD和SWD患者的CSF-β-淀粉样蛋白(1-42)显著降低,且与FTD患者相比,AD患者的CSF-β-淀粉样蛋白(1-42)也显著降低。仅在PD患者中CSF-GAP-43显著降低。与对照组相比,除心境恶劣组外,所有患者组的GAP-43/tau比值均降低。所有组中CSF-GAP-43与CSF-tau之间均呈正相关。结果表明FTD患者的CSF-tau和CSF-β-淀粉样蛋白(1-42)水平正常,这将有助于FTD与AD的临床鉴别。在SWD中,CSF-β-淀粉样蛋白(1-42)水平降低提示血管和淀粉样蛋白机制同时受累。